2015
DOI: 10.1016/j.lungcan.2015.09.020
|View full text |Cite
|
Sign up to set email alerts
|

Endosonography for lung cancer staging: predictors for false-negative outcomes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
1
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 14 publications
(3 citation statements)
references
References 23 publications
2
1
0
Order By: Relevance
“…In the present study, the rate of false negative results on N2/3 LNs by EBUS/EUS-NA was 111/705 (15.7%). Among the patients with false negative results, 24/111 (21.6%) had false negative results to inaccessible LNs, and these rates were similar to those reported in previous studies [9, 10]. Previous studies have identified several factors associated with false negative results of EBUS/EUS-NA [9, 10, 17], including primary tumor location (central or left lung), abnormal findings of mediastinal LNs on CT and/or PET, inadequacy of the sampling, internal necrosis in the LNs, and rare cancer types.…”
Section: Discussionsupporting
confidence: 88%
See 2 more Smart Citations
“…In the present study, the rate of false negative results on N2/3 LNs by EBUS/EUS-NA was 111/705 (15.7%). Among the patients with false negative results, 24/111 (21.6%) had false negative results to inaccessible LNs, and these rates were similar to those reported in previous studies [9, 10]. Previous studies have identified several factors associated with false negative results of EBUS/EUS-NA [9, 10, 17], including primary tumor location (central or left lung), abnormal findings of mediastinal LNs on CT and/or PET, inadequacy of the sampling, internal necrosis in the LNs, and rare cancer types.…”
Section: Discussionsupporting
confidence: 88%
“…Among the patients with false negative results, 24/111 (21.6%) had false negative results to inaccessible LNs, and these rates were similar to those reported in previous studies [9, 10]. Previous studies have identified several factors associated with false negative results of EBUS/EUS-NA [9, 10, 17], including primary tumor location (central or left lung), abnormal findings of mediastinal LNs on CT and/or PET, inadequacy of the sampling, internal necrosis in the LNs, and rare cancer types. Although we did not perform multivariate analysis to identify the independent patient and tumor characteristics associated with false negative results, young age, female gender, inaccessible stations by EBUS, and larger size of LNs had a trend for higher false negative rates (Tables 1 and 2).…”
Section: Discussionsupporting
confidence: 88%
See 1 more Smart Citation